Table 9.
RA/CPX | ||
ESC | maGSC | |
Actb1 | 2.17 | 1.10 |
Aldh2 | 2.61 | 2.17 |
Aldh2 | 2.43 | 1.21 |
Aprt1 | 2.20 | 1.42 |
Atp5b | 1.15 | 2.17 |
Capzb | 2.79 | 2.07 |
Cct2*1 | 13.70 | 2.77 |
Eno11 | 2.48 | 2.02 |
Eno11 | 2.71 | 1.51 |
Fscn1 | 2.20 | 2.14 |
Gnb2l1 | 1.81 | 2.24 |
Hist1h2bb | 7.53 | 1.62 |
Hist2h2ac | 3.89 | 211.81 |
Hnrnpk | 2.37 | 1.58 |
Hsp90aa1*1 | 2.69 | 6.36 |
Hsp90aa1 | 6.36 | 4.33 |
Hspa4*1 | 12.98 | 3.72 |
Hspa4 | 1.35 | 3.42 |
Krt7 | > 100 | 1.14 |
Krt18*1 | 4.04 | 1.76 |
Ncl | 1.80 | 3.48 |
Nme11 | 2.63 | 1.57 |
Nme2*1 | 5.72 | 11.15 |
Pdia6 | 1.74 | 6.33 |
Psmc21 | 2.87 | 1.20 |
Psmc4*1 | 3.06 | 2.26 |
Rps12*1 | 2 | 2.05 |
Tardbp | 1.11 | 3.85 |
Uchl11 | 2.02 | 1.10 |
Vcp1 | 8.94 | 2.57 |
The proteins are referred to in the text and following tables;
The protein was not identified in embryonic stem cells. Proteins, which are assigned an asterisk, were downregulated upon ciclopirox olamine (CPX) treatment compared to control and concurrently upregulated upon retinoic acid (RA) treatment compared to control. ESC: Embryonic stem cell; maGSC: Multipotent adult germline stem cell.